Described herein are compounds of formula (I), and pharmaceutically acceptable salts, solvates, hydrates, isotopically labeled derivatives and radiolabeled derivative thereof, and pharmaceutical compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for detecting and imaging Tau aggregates in the brain for detection of Alzheimer's disease (AD) in a subject.

Provided is a composition which can be used for formation of an optical film having high quality and a high dichroic ratio even after the composition is stored for a predetermined period of time. The composition includes a compound represented by the general formula (A) and a compound represented by the general formula (B), wherein R.sup.1a in the general formula (A) and R.sup.1b in the general formula (B) are mutually different groups.

R.sup.1a—Ar.sup.1a—N═N—Ar.sup.2a—N═N—Ar.sup.3a—R.sup.10a   (A)

R.sup.1b—Ar.sup.1b—N═N—Ar.sup.2b—N═N—Ar.sup.3b—R.sup.10a   (B)

The present invention relates to a formulation comprising at least one organofunctional material which can be employed for the production of functional layers of electronic devices, and at least one aromatic compound. The present invention furthermore relates to electronic devices which are obtainable from these formulations.

A polymer having excellent liquid crystal alignment and electrical properties and thus is suitable for use as a liquid crystal alignment agent, a liquid crystal alignment agent including the same, a liquid crystal alignment film formed from the liquid crystal alignment agent, and a liquid crystal display device including the liquid crystal alignment film are provided.

Described herein are compounds of formula (I), and pharmaceutically acceptable salts, solvates, hydrates, isotopically labeled derivatives and radiolabeled derivative thereof, and pharmaceutical compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for detecting and imaging Tau aggregates in the brain for detection of Alzheimer's disease (AD) in a subject.

A liquid crystal display according to an exemplary embodiment of the present invention includes: a first display panel and a second display panel. A liquid crystal layer is between the first display panel and the second display panel with a sealant therebetween. The first display panel includes a display area and a non-display area. First light blocking members are disposed in the non-display area. The liquid crystal layer includes a plurality of liquid crystal molecules and a plurality of protrusions. The protrusions are adjacent to at least one of the first display panel or the second display panel. The protrusions include a polymer including a compound represented by Chemical Formula 1 or a polymer including a compound represented by Chemical Formula 2: ##STR00001##

A polymer having excellent liquid crystal alignment and electrical properties and thus is suitable for use as a liquid crystal alignment agent, a liquid crystal alignment agent including the same, a liquid crystal alignment film formed from the liquid crystal alignment agent, and a liquid crystal display device including the liquid crystal alignment film are provided.

The present invention relates to a formulation comprising at least one organofunctional material which can be employed for the production of functional layers of electronic devices, and at least one aromatic compound. The present invention furthermore relates to electronic devices which are obtainable from these formulations.

Provided are a reactive mesogen that may improve display quality of a liquid crystal display, and a liquid crystal composition including the same. The reactive mesogen is represented by the following Formula:

BZ.sub.1.sub.b1XZ.sub.2.sub.b2Pa where X, Z1, Z2, B, and Pa are specified in the disclosure, and each of b1 and b2 is independently an integer between 0 to 6, inclusive.

A liquid crystal display according to an exemplary embodiment of the present invention includes: a first display panel and a second display panel. A liquid crystal layer is between the first display panel and the second display panel with a sealant therebetween. The first display panel includes a display area and a non-display area. First light blocking members are disposed in the non-display area. The liquid crystal layer includes a plurality of liquid crystal molecules and a plurality of protrusions. The protrusions are adjacent to at least one of the first display panel or the second display panel. The protrusions include a polymer including a compound represented by Chemical Formula 1 or a polymer including a compound represented by Chemical Formula 2:

##STR00001##